Table of Contents Author Guidelines Submit a Manuscript

Citations to this Journal [595 citations: 1–100 of 590 articles]

Articles published in Chemotherapy Research and Practice have been cited 595 times. The following is a list of the 590 articles that have cited the articles published in Chemotherapy Research and Practice.

  • Richard J. Browning, Philip James Thomas Reardon, Maryam Parhizkar, R. Barbara Pedley, Mohan Edirisinghe, Jonathan C. Knowles, and Eleanor Stride, “Drug Delivery Strategies for Platinum-Based Chemotherapy,” ACS Nano, 2017. View at Publisher · View at Google Scholar
  • Majid Avijgan, Mahsa Alinaghian, and Masoud Hafizi Esfahani, “Aloe Vera Gel as a Traditional and Complementary Method for Chronic Skin Burn: A Case Report,” Advances in Infectious Diseases, vol. 07, no. 01, pp. 19–25, 2017. View at Publisher · View at Google Scholar
  • Damian Neubauer, Maciej Jaśkiewicz, Dorian Migoń, Marta Bauer, Karol Sikora, Emilia Sikorska, Elżbieta Kamysz, and Wojciech Kamysz, “Retro analog concept: comparative study on physico-chemical and biological properties of selected antimicrobial peptides,” Amino Acids, 2017. View at Publisher · View at Google Scholar
  • Lanshuang Hu, Shengqiang Hu, Linyan Guo, Congcong Shen, Minghui Yang, and Avraham Rasooly, “DNA Generated Electric Current Biosensor,” Analytical Chemistry, 2017. View at Publisher · View at Google Scholar
  • Sarita Das, Neha Tripathi, Sumit Siddharth, Anmada Nayak, Deepika Nayak, Chinmayee Sethy, Prasad V. Bharatam, and Chanakya Nath Kundu, “Etoposide and doxorubicin enhance the sensitivity of triple negative breast cancers through modulation of TRAIL-DR5 axis,” Apoptosis, 2017. View at Publisher · View at Google Scholar
  • Lisanne Verhoef, David Baartz, Shona Morrison, Karen Sanday, and Andrea Janet Garrett, “Outcomes of women diagnosed and treated for low-risk gestational trophoblastic neoplasia at the Queensland Trophoblast Centre (QTC),” Australian and New Zealand Journal of Obstetrics and Gynaecology, 2017. View at Publisher · View at Google Scholar
  • Li Hui Tan, Peter H Sykes, Maan M Alkaisi, and John J Evans, “Cell-like features imprinted in the physical nano- and micro-topography of the environment modify the responses to anti-cancer drugs of endometrial cancer cells,” Biofabrication, vol. 9, no. 1, pp. 015017, 2017. View at Publisher · View at Google Scholar
  • Songtao Gao, Jacson Shen, Francis Hornicek, and Zhenfeng Duan, “Three-dimensional (3D) culture in sarcoma research and the clinical significance,” Biofabrication, vol. 9, no. 3, pp. 032003, 2017. View at Publisher · View at Google Scholar
  • Frederick S. Kaplan, Jeffrey R. Andolina, Peter C. Adamson, David T. Teachey, Jerry Z. Finklestein, David H. Ebb, Benjamin Whitehead, Benjamin Jacobs, David M. Siegel, Richard Keen, Edward Hsiao, and Robert J. Pignolo, “Early clinical observations on the use of imatinib mesylate in FOP: A report of seven cases,” Bone, 2017. View at Publisher · View at Google Scholar
  • Zuhal Hamurcu, Nermin Kahraman, Ahmed Ashour, and Bulent Ozpolat, “FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer,” Breast Cancer Research and Treatment, 2017. View at Publisher · View at Google Scholar
  • Moaath Mustafa Ali, Machelle Moeller, Lisa Rybicki, and Halle C. F. Moore, “Long-term peripheral neuropathy symptoms in breast cancer survivors,” Breast Cancer Research and Treatment, 2017. View at Publisher · View at Google Scholar
  • Jukapun Yoodee, Unchalee Permsuwan, and Mantiwee Nimworapan, “Efficacy and safety of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis,” Critical Reviews in Oncology/Hematology, vol. 112, pp. 113–125, 2017. View at Publisher · View at Google Scholar
  • Stefano Giovagnoli, Aurelie Schoubben, and Maurizio Ricci, “The long and winding road to inhaled TB therapy: not only the bug’s fault,” Drug Development and Industrial Pharmacy, pp. 1–17, 2017. View at Publisher · View at Google Scholar
  • Ashenafi Genanew Desta, Mohammedbrhan Abdelwuhab, Wondmagegn Tamiru Tadesse, and Abyot Endale Gurmu, “In vitro antibacterial activities of the leaf extracts of Aloe macrocarpa Tod (Aloaceae),” European Journal of Integrative Medicine, vol. 12, pp. 74–78, 2017. View at Publisher · View at Google Scholar
  • Heidi M. Kieler-Ferguson, Darren Chan, Jonathan Sockolosky, Lydia Finney, Evan Maxey, Stefan Vogt, and Francis C. Szoka, “Encapsulation, controlled release, and antitumor efficacy of cisplatin delivered in liposomes composed of sterol-modified phospholipids,” European Journal of Pharmaceutical Sciences, 2017. View at Publisher · View at Google Scholar
  • Yun Cai, Boxin Zhao, Qianying Liang, Yunqi Zhang, Jieying Cai, and Guofeng Li, “The selective effect of Glycyrrhizin and Glycyrrhetinic acid on topoisomerase IIα and apoptosis in combination with etoposide on triple negative breast cancer MDA-MB-231 cells,” European Journal of Pharmacology, 2017. View at Publisher · View at Google Scholar
  • Rafael Llombart-Blanco, Carlos Villas, Álvaro Silva, Azucena Aldaz, Iñigo Navarro, Jeronimo Forteza, Salvador Martin Algarra, and Matías Alfonso, “Local and systemic diffusion of antineoplastic drugs following vertebroplasty using acrylic cement mixed with cisplatin or methotrexate: experimental study in pigs,” European Spine Journal, 2017. View at Publisher · View at Google Scholar
  • Tess M. E. Derksen, Martijn J. L. Bours, Floortje Mols, and Matty P. Weijenberg, “Lifestyle-Related Factors in the Self-Management of Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer: A Systematic Review,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, pp. 1–14, 2017. View at Publisher · View at Google Scholar
  • Yuki Mochida, Horacio Cabral, and Kazunori Kataoka, “Polymeric micelles for targeted tumor therapy of platinum anticancer drugs,” Expert Opinion on Drug Delivery, pp. 1–16, 2017. View at Publisher · View at Google Scholar
  • Atefeh Taherian Fard, and Mark A. Ragan, “Modeling the Attractor Landscape of Disease Progression: a Network-Based Approach,” Frontiers in Genetics, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Kristina M. Ilieva, Judit Fazekas-Singer, Daniela Y. Achkova, Tihomir S. Dodev, Silvia Mele, Silvia Crescioli, Heather J. Bax, Anthony Cheung, Panagiotis Karagiannis, Isabel Correa, Mariangela Figini, Rebecca Marlow, Debra H. Josephs, Andrew J. Beavil, John Maher, James F. Spicer, Erika Jensen-Jarolim, Andrew N. Tutt, and Sophia N. Karagiannis, “Functionally Active Fc Mutant Antibodies Recognizing Cancer Antigens Generated Rapidly at High Yields,” Frontiers in Immunology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Sayaka Tsuchida, Fumito Maruyama, Yoshitoshi Ogura, Atsushi Toyoda, Tetsuya Hayashi, Moriya Okuma, and Kazunari Ushida, “Genomic Characteristics of Bifidobacterium thermacidophilum Pig Isolates and Wild Boar Isolates Reveal the Unique Presence of a Putative Mobile Genetic Element with tetW for Pig Farm Isolates,” Frontiers in Microbiology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Hana Starobova, and Irina Vetter, “Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy,” Frontiers in Molecular Neuroscience, vol. 10, 2017. View at Publisher · View at Google Scholar
  • Nicolas Kerckhove, Aurore Collin, Sakahlé Condé, Carine Chaleteix, Denis Pezet, and David Balayssac, “Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review,” Frontiers in Pharmacology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Sumi Yun, Jiwon Koh, Soo Kyung Nam, Jung Ok Park, Sung Mi Lee, Kyoungyul Lee, Kyu Sang Lee, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Gheeyoung Choe, Woo Ho Kim, and Hye Seung Lee, “Clinical significance of overexpression of NRG1 and its receptors, HER3 and HER4, in gastric cancer patients,” Gastric Cancer, 2017. View at Publisher · View at Google Scholar
  • Love, Parente, Porter, Ross, Siderov, Thomas, Rischin, Blum, Burbury, Dooley, Ismail, Alexander, Opat, White, Kirsa, Coutsouvelis, Fazil, Griffiths, and Joshi, “Timely initiation of chemotherapy: a systematic literature review of six priority cancers – results and recommendations for clinical practice,” Internal Medicine Journal, vol. 47, no. 1, pp. 16–34, 2017. View at Publisher · View at Google Scholar
  • Xiaoqiu Wu, Atik Shaikh, Yuanyuan Yu, Yongshu Li, Shuaijian Ni, Aiping Lu, and Ge Zhang, “Potential Diagnostic and Therapeutic Applications of Oligonucleotide Aptamers in Breast Cancer,” International Journal of Molecular Sciences, vol. 18, no. 9, pp. 1851, 2017. View at Publisher · View at Google Scholar
  • B.S. Pruthvishree, O.R. Vinodh Kumar, D.K. Sinha, Y.P.S. Malik, Z.B. Dubal, P.A. Desingu, M. Shivakumar, N. Krishnaswamy, and B.R. Singh, “ Spatial molecular epidemiology of carbapenem-resistant and New Delhi metallo beta-lactamase ( bla NDM)-producing Escherichia coli in the piglets of organized farms in India ,” Journal of Applied Microbiology, 2017. View at Publisher · View at Google Scholar
  • Chang-Ning Liu, Edwin Berryman, David Zakur, Ahmed M. Shoieb, Ingrid D. Pardo, Magalie Boucher, Chris J. Somps, Chedo M. Bagi, and Jon C. Cook, “A novel endpoint for the assessment of chemotherapy-induced peripheral neuropathy in rodents: biomechanical properties of peripheral nerve,” Journal of Applied Toxicology, 2017. View at Publisher · View at Google Scholar
  • Heba A. Sayed, Abeer Refaiy, and Mohammed A. Salem, “Prognostic Impact of HER/2 Expression on Survival of Preoperatively Treated Children with Wilms Tumor at South Egypt,” Journal of Cancer Therapy, vol. 08, no. 09, pp. 801–813, 2017. View at Publisher · View at Google Scholar
  • Reza Nedaeinia, Amir Avan, Mehdi Ahmadian, Sasan Nedaee Nia, Maryam Ranjbar, Mohammadreza Sharifi, Mohammad Goli, Ahmad Piroozmand, Esmail Nourmohammadi, Mostafa Manian, Gordon A. Ferns, Majid Ghayour-Mobarhan, and Rasoul Salehi, “Current Status and Perspectives Regarding LNA-Anti-miR Oligonucleotides and microRNA miR-21 Inhibitors as a Potential Therapeutic Option in Treatment of Colorectal Cancer,” Journal of Cellular Biochemistry, 2017. View at Publisher · View at Google Scholar
  • Maryam Zare, Milad Bastami, Saeed Solali, and Mohammad Reza Alivand, “Aberrant miRNA promoter methylation and EMT-involving miRNAs in breast cancer metastasis: Diagnosis and therapeutic implications,” Journal of Cellular Physiology, 2017. View at Publisher · View at Google Scholar
  • Jaleh Varshosaz, Mohammad Ali Davoudi, and Sara Rasoul-Amini, “Docetaxel-loaded nanostructured lipid carriers functionalized with trastuzumab (Herceptin) for HER2-positive breast cancer cells,” Journal of Liposome Research, pp. 1–11, 2017. View at Publisher · View at Google Scholar
  • Darya B. Rose, Dave Nellesen, Maureen P. Neary, and Beilei Cai, “Budget impact of everolimus for the treatment of progressive, well-differentiated, non-functional neuroendocrine tumors of gastrointestinal or lung origin that are advanced or metastatic,” Journal of Medical Economics, pp. 1–10, 2017. View at Publisher · View at Google Scholar
  • Roberto Jose Diaz, Sheikh Ali, Mehreen Gull Qadir, Macarena I. De La Fuente, Michael E. Ivan, and Ricardo J. Komotar, “The role of bevacizumab in the treatment of glioblastoma,” Journal of Neuro-Oncology, 2017. View at Publisher · View at Google Scholar
  • Leila Farzin, and Mojtaba Shamsipur, “Recent advances in design of electrochemical affinity biosensors for low level detection of cancer protein biomarkers using nanomaterial-assisted signal enhancement strategies,” Journal of Pharmaceutical and Biomedical Analysis, 2017. View at Publisher · View at Google Scholar
  • Jose Antonio Medina, Maria Isabel Queipo, Lidia Perez-Villa, Alicia Roman, Vanessa De Luque, Eloisa Bayo, Jaime Gomez-Millan, Maria del Mar Delgado, Fernando De la Portilla, and Esperanza Torres, “The impact of body mass index and nuclear β-catenin on survival in locally advanced rectal cancer treated with preoperative radiochemotherapy,” Journal of Surgical Oncology, vol. 115, no. 3, pp. 301–306, 2017. View at Publisher · View at Google Scholar
  • Liviane D. Azevedo, Mônica M. Bastos, Flávia C. Vasconcelos, Lucas V. B. Hoelz, Floriano P. S. Junior, Rafael F. Dantas, Ana C. M. de Almeida, Andressa Paula de Oliveira, Larissa C. Gomes, Raquel C. Maia, and Nubia Boechat, “Imatinib derivatives as inhibitors of K562 cells in chronic myeloid leukemia,” Medicinal Chemistry Research, 2017. View at Publisher · View at Google Scholar
  • Ziad Daoud, Jina Farah, Elie S. Salem, Khalil El Kfoury, Elias Dahdouh, Khalil Masri, Claude Afif, Roula M. Abdel-Massih, and Ghassan M. Matar, “Multidrug-Resistant Enterobacteriaceae in Lebanese Hospital Wastewater: Implication in the One Health Concept,” Microbial Drug Resistance, 2017. View at Publisher · View at Google Scholar
  • Ilja Bobylev, Abhijeet R. Joshi, Mohammed Barham, Wolfram F. Neiss, and Helmar C. Lehmann, “Depletion of Mitofusin-2 Causes Mitochondrial Damage in Cisplatin-Induced Neuropathy,” Molecular Neurobiology, 2017. View at Publisher · View at Google Scholar
  • John S. Schardt, Jinan M. Oubaid, Sonya C. Williams, James L. Howard, Chloe M. Aloimonos, Michelle L. Bookstaver, Tek N. Lamichhane, Sonja Sokic, Mariya S. Liyasova, Maura O’Neill, Thorkell Andresson, Arif Hussain, Stanley Lipkowitz, and Steven M. Jay, “Engineered Multivalency Enhances Affibody-Based HER3 Inhibition and Downregulation in Cancer Cells,” Molecular Pharmaceutics, 2017. View at Publisher · View at Google Scholar
  • Ananda Kumar Kanduluru, and Philip S. Low, “Development of a Ligand-Targeted Therapeutic Agent for Neurokinin-1 Receptor Expressing Cancers,” Molecular Pharmaceutics, 2017. View at Publisher · View at Google Scholar
  • Petronela Imreova, Jana Feruszova, Stanislav Kyzek, Kristina Bodnarova, Martina Zduriencikova, Katarina Kozics, Pavel Mucaji, Eliska Galova, Andrea Sevcovicova, Eva Miadokova, and Ivan Chalupa, “Hyperforin Exhibits Antigenotoxic Activity on Human and Bacterial Cells,” Molecules, vol. 22, no. 1, pp. 167, 2017. View at Publisher · View at Google Scholar
  • Jiri Grim, Alena Ticha, Radomir Hyspler, Martin Valis, and Zdenek Zadak, “Selected Risk Nutritional Factors for Chemotherapy-Induced Polyneuropathy,” Nutrients, vol. 9, no. 6, pp. 535, 2017. View at Publisher · View at Google Scholar
  • K Zhang, S-M Myllymäki, P Gao, R Devarajan, V Kytölä, M Nykter, G-H Wei, and A Manninen, “Oncogenic K-Ras upregulates ITGA6 expression via FOSL1 to induce anoikis resistance and synergizes with αV-Class integrins to promote EMT,” Oncogene, 2017. View at Publisher · View at Google Scholar
  • Daniel F. Carr, Seyoum Ayehunie, Andrea Davies, Carrie A. Duckworth, Stephanie French, Neil Hall, Syed Hussain, Howard R. Mellor, Alan Norris, B. Kevin Park, Alexander Penrose, D. Mark Pritchard, Chris S. Probert, Shashi Ramaiah, Claire Sadler, Michael Schmitt, Alison Shaw, James E. Sidaway, Robert G. Vries, Matthew Wagoner, and Munir Pirmohamed, “Towards better models and mechanistic biomarkers for drug-induced gastrointestinal injury,” Pharmacology & Therapeutics, 2017. View at Publisher · View at Google Scholar
  • Dane A. Hayes, Dale A. Kunde, Robyn L. Taylor, Stephen B. Pyecroft, Sukhwinder Singh Sohal, and Elizabeth T. Snow, “ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1),” Plos One, vol. 12, no. 6, pp. e0177919, 2017. View at Publisher · View at Google Scholar
  • Judith Schwartzbaum, Min Wang, Elisabeth Root, Maciej Pietrzak, Grzegorz A. Rempala, Ruo-Pan Huang, Tom Borge Johannesen, and Tom K. Grimsrud, “A nested case-control study of 277 prediagnostic serum cytokines and glioma,” Plos One, vol. 12, no. 6, pp. e0178705, 2017. View at Publisher · View at Google Scholar
  • Wen Che, Yun Bao, and Feng Tang, “Down-regulation of C35 decreased the cell viability and migration of breast ductal carcinoma cells,” Plos One, vol. 12, no. 8, pp. e0183941, 2017. View at Publisher · View at Google Scholar
  • Atefeh Razazan, Javad Behravan, Atefeh Arab, Nastaran Barati, Leila Arabi, Zahra Gholizadeh, Mahdi Hatamipour, Amin Reza Nikpoor, Amir Abbas Momtazi-Borojeni, Fatemeh Mosaffa, Mohamad Hosein Ghahremani, and Mahmoud Reza Jaafari, “Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model,” Plos One, vol. 12, no. 10, pp. e0185099, 2017. View at Publisher · View at Google Scholar
  • Yongjia Hao, Jiankun Lyu, Rong Qu, Deheng Sun, Zhenjiang Zhao, Zhuo Chen, Jian Ding, Hua Xie, Yufang Xu, and Honglin Li, “Structure-Guided Design of C4-alkyl-1,4-dihydro-2H-pyrimido[4,5-d][1,3]oxazin-2-ones as Potent and Mutant-Selective Epidermal Growth Factor Receptor (EGFR) L858R/T790M Inhibitors,” Scientific Reports, vol. 7, no. 1, 2017. View at Publisher · View at Google Scholar
  • Sara S. Barakat, Maha Nasr, Rania F. Ahmed, Sabry S. Badawy, and Samar Mansour, “Intranasally administered in situ gelling nanocomposite system of dimenhydrinate: preparation, characterization and pharmacodynamic applicability in chemotherapy induced emesis model,” Scientific Reports, vol. 7, no. 1, 2017. View at Publisher · View at Google Scholar
  • Mihaela N. Mocanu, and Fei Yan, “Ultrasound-assisted interaction between chlorin-e6 and human serum albumin: pH dependence, singlet oxygen production, and formulation effect,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2017. View at Publisher · View at Google Scholar
  • Benjamin Grabowski, M. Alexander Schmidt, and Christian Rüter, “Immunomodulatory Yersinia outer proteins (Yops) -useful tools for bacteria and humans alike,” Virulence, pp. 00–00, 2017. View at Publisher · View at Google Scholar
  • Gan Liu, Hongjun Gao, Yixiong Zuo, Xiaowei Zeng, Wei Tao, Hsiang-i Tsai, and Lin Mei, “DACHPt-Loaded Unimolecular Micelles Based on Hydrophilic Dendritic Block Copolymers for Enhanced Therapy of Lung Cancer,” ACS Applied Materials & Interfaces, 2016. View at Publisher · View at Google Scholar
  • Shubham Jain, Sai Rama Krishna Meka, and Kaushik Chatterjee, “Engineering a Piperine Eluting Nanofibrous Patch for Cancer Treatment,” ACS Biomaterials Science & Engineering, 2016. View at Publisher · View at Google Scholar
  • Anna Klimaszewska-Wiśniewska, Marta Hałas-Wiśniewska, Magdalena Izdebska, Maciej Gagat, Alina Grzanka, and Dariusz Grzanka, “Antiproliferative and antimetastatic action of quercetin on A549 non-small cell lung cancer cells through its effect on the cytoskeleton,” Acta Histochemica, 2016. View at Publisher · View at Google Scholar
  • Xuli Meng, Yongfeng Li, Hongchao Tang, Weimin Mao, Hongjian Yang, Xiaojia Wang, Xianfeng Ding, and Shangnao Xie, “Drug response to HER2 gatekeeper T798M mutation in HER2-positive breast cancer,” Amino Acids, vol. 48, no. 2, pp. 487–497, 2016. View at Publisher · View at Google Scholar
  • Christian B. Theodotou, Ashish H. Shah, Michael E. Ivan, and Ricardo J. Komotar, “Subdural hematoma in a patient taking imatinib for GIST: a case report and discussion of risk with other chemotherapeutics,” Anti-Cancer Drugs, vol. 27, no. 3, pp. 259–263, 2016. View at Publisher · View at Google Scholar
  • Giovanna Pulcrano, Salvatore Pignanelli, Adriana Vollaro, Matilde Esposito, Vita Dora Iula, Emanuela Roscetto, Amata Amy Soriano, and Maria Rosaria Catania, “Isolation of Enterobacter aerogenes carrying bla(TEM-1) and blaKPC-3 genes recovered from a hospital Intensive Care Unit,” Apmis, vol. 124, no. 6, pp. 516–521, 2016. View at Publisher · View at Google Scholar
  • Tao-Wei Ke, Hua-Che Chiang, Sheng-Chi Chang, Pin-Hui Wang, Yi-Ya Chen, William Tzu-Liang Chen, Yu-Min Liao, and Chun-Ru Chien, “Effectiveness of neoadjuvant concurrent chemoradiotherapy versus up-front proctectomy in clinical stage II–III rectal cancer: A population-based study,” Asia-Pacific Journal of Clinical Oncology, vol. 12, no. 2, pp. e234–e240, 2016. View at Publisher · View at Google Scholar
  • Kevser Erol, Semra Yigitaslan, Cigdem Unel, Bilgin Kaygisiz, and Engin Yildirim, “Evaluation of Cisplatin Neurotoxicity in Cultured Rat Dorsal Root Ganglia via Cytosolic Calcium Accumulation,” Balkan Medical Journal, vol. 33, no. 2, pp. 144–151, 2016. View at Publisher · View at Google Scholar
  • Amanda Canas, Laura M. Lopez-Sanchez, Jon Penarando, Araceli Valverde, Francisco Conde, Vanessa Hernandez, Elena Fuentes, Chary Lopez-Pedrera, Juan R. de la Haba-Rodriguez, Enrique Aranda, and Antonio Rodriguez-Ariza, “Altered S-nitrosothiol homeostasis provides a survival advantage to breast cancer cells in HER2 tumors and reduces their sensitivity to trastuzumab,” Biochimica Et Biophysica Acta-Molecular Basis Of Disease, vol. 1862, no. 4, pp. 601–610, 2016. View at Publisher · View at Google Scholar
  • Chiara Da Pieve, Louis Allott, Carlos D. Martins, Andrew Vardon, Daniela M. Ciobota, Gabriela Kramer-Marek, and Graham Smith, “ Efficient [ 18 F]AlF Radiolabeling of Z HER3:8698 Affibody Molecule for Imaging of HER3 Positive Tumors ,” Bioconjugate Chemistry, 2016. View at Publisher · View at Google Scholar
  • Pooja Khandelwal, Sabine Mellor-Heineke, Najibah Rehman, Adam Lane, Kristi Smiley, Joyce Villanueva, Rebecca A. Marsh, Michael S. Grimley, Stella M. Davies, and Alexandra H. Filipovich, “Cytokine Profile of Engraftment Syndrome in Pediatric Hematopoietic Stem Cell Transplant Recipients,” Biology Of Blood And Marrow Transplantation, vol. 22, no. 4, pp. 690–697, 2016. View at Publisher · View at Google Scholar
  • Gerhardt J. Boukes, and Maryna van de Venter, “The apoptotic and autophagic properties of two natural occurring prodrugs, hyperoside and hypoxoside, against pancreatic cancer cell lines,” Biomedicine & Pharmacotherapy, vol. 83, pp. 617–626, 2016. View at Publisher · View at Google Scholar
  • Silvia Martin Lluesma, Anita Wolfer, Alexandre Harari, and Lana Kandalaft, “Cancer Vaccines in Ovarian Cancer: How Can We Improve?,” Biomedicines, vol. 4, no. 2, pp. 10, 2016. View at Publisher · View at Google Scholar
  • Kyla R. Rodgers, and Richard C. Chou, “Therapeutic monoclonal antibodies and derivatives: Historical perspectives and future directions,” Biotechnology Advances, 2016. View at Publisher · View at Google Scholar
  • A. J. Nabill Haniff, and Lay-Harn Gam, “Identification of urinary protein biomarkers for tobacco smoking,” Biotechnology And Applied Biochemistry, vol. 63, no. 2, pp. 266–272, 2016. View at Publisher · View at Google Scholar
  • Christina Cho, Carol Horzempa, David Jones, and Paula J. McKeown-Longo, “The fibronectin III-1 domain activates a PI3-Kinase/Akt signaling pathway leading to αvβ5 integrin activation and TRAIL resistance in human lung cancer cells,” BMC Cancer, vol. 16, no. 1, 2016. View at Publisher · View at Google Scholar
  • T. Kredo, K. Mauff, L. Workman, J. S. Van der Walt, L. Wiesner, P. J. Smith, G. Maartens, K. Cohen, and K. I. Barnes, “The interaction between artemether-lumefantrine and lopinavir/ritonavir-based antiretroviral therapy in HIV-1 infected patients,” Bmc Infectious Diseases, vol. 16, 2016. View at Publisher · View at Google Scholar
  • Himanshu Pandey, Radha Rani, and Vishnu Agarwal, “Liposome and Their Applications in Cancer Therapy,” Brazilian Archives Of Biology And Technology, vol. 59, 2016. View at Publisher · View at Google Scholar
  • Anna G. Sorace, C. Chad Quarles, Jennifer G. Whisenant, Ariella B. Hanker, J. Oliver McIntyre, Violeta M. Sanchez, and Thomas E. Yankeelov, “Trastuzumab improves tumor perfusion and vascular delivery of cytotoxic therapy in a murine model of HER2+breast cancer: preliminary results,” Breast Cancer Research And Treatment, vol. 155, no. 2, pp. 273–284, 2016. View at Publisher · View at Google Scholar
  • Guy T. Clifton, Victor Gall, George E. Peoples, and Elizabeth A. Mittendorf, “Clinical Development of the E75 Vaccine in Breast Cancer,” Breast Care, vol. 11, no. 2, pp. 116–121, 2016. View at Publisher · View at Google Scholar
  • Anna Klimaszewska-Wisniewska, Marta Halas-Wisniewska, Tadeusz Tadrowski, Maciej Gagat, Dariusz Grzanka, and Alina Grzanka, “Paclitaxel and the dietary flavonoid fisetin: a synergistic combination that induces mitotic catastrophe and autophagic cell death in A549 non-small c,” Cancer Cell International, vol. 16, 2016. View at Publisher · View at Google Scholar
  • Quan Zhang, Tianyu Sun, Poming Kang, Kai Qian, Bo Deng, Jinghai Zhou, Ruwen Wang, Bin Jiang, Kun Li, Fang Liu, Shiyang Wu, and Qunyou Tan, “Combined analysis of rearrangement of ALK, ROS1, somatic mutation of EGFR, KRAS, BRAF, PIK3CA, and mRNA expression of ERCC1, TYMS, RRM1, TUBB3, EGFR i,” Cancer Chemotherapy And Pharmacology, vol. 77, no. 3, pp. 583–593, 2016. View at Publisher · View at Google Scholar
  • D. A. Fennell, Y. Summers, J. Cadranel, T. Benepal, D. C. Christoph, R. Lal, M. Das, F. Maxwell, C. Visseren-Grul, and D. Ferry, “Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer,” Cancer Treatment Reviews, vol. 44, pp. 42–50, 2016. View at Publisher · View at Google Scholar
  • Kevin Kelley, Jonathan Knisely, Marc Symons, and Rosamaria Ruggieri, “Radioresistance of Brain Tumors,” Cancers, vol. 8, no. 4, pp. 42, 2016. View at Publisher · View at Google Scholar
  • Amanda Rinkenbaugh, and Albert Baldwin, “The NF-κB Pathway and Cancer Stem Cells,” Cells, vol. 5, no. 2, pp. 16, 2016. View at Publisher · View at Google Scholar
  • Sayantan Bhattacharyya, Vasanthakumar Sekar, Biswanath Majumder, Debapriya G Mehrotra, Samir Banerjee, Anup K Bhowmick, Neyaz Alam, Gautam K Mandal, Jaydip Biswas, Pradip K Majumder, and Nabendu Murmu, “CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer,” Cellular Oncology, 2016. View at Publisher · View at Google Scholar
  • Mahmoud Labib, Edward H. Sargent, and Shana O. Kelley, “Electrochemical Methods for the Analysis of Clinically Relevant Biomolecules,” Chemical Reviews, 2016. View at Publisher · View at Google Scholar
  • Pradeepkumar L. Patel, Niki K. Rana, Mayurbhai R. Patel, Stephen D. Kozuch, and David Sabatino, “Nucleic Acid Bioconjugates in Cancer Detection and Therapy,” Chemmedchem, vol. 11, no. 3, pp. 252–269, 2016. View at Publisher · View at Google Scholar
  • Pavlos Msaouel, Miao Zhang, and Shi-Ming Tu, “Prolonged Remission of Upper Urinary Tract Urothelial Carcinoma With Prominent Choriocarcinomatous Differentiation: A Case Report,” Clinical Genitourinary Cancer, 2016. View at Publisher · View at Google Scholar
  • Tiffany Field, “Massage therapy research review,” Complementary Therapies in Clinical Practice, 2016. View at Publisher · View at Google Scholar
  • T. Srikumar, M. Markow, B. Centeno, S. Hoffe, J. Tao, H. Fernandez, J. Strosberg, and D. Shibata, “Synchronous rectal adenocarcinoma and splenic marginal zone lymphoma,” Current Oncology, vol. 23, no. 1, pp. E70–E74, 2016. View at Publisher · View at Google Scholar
  • Diana R. Julie, and Karyn A. Goodman, “Advances in the Management of Anal Cancer,” Current Oncology Reports, vol. 18, no. 3, 2016. View at Publisher · View at Google Scholar
  • Gautham Gampa, Shruthi Vaidhyanathan, Brynna Wilken-Resman, Karen E. Parrish, Svetomir N. Markovic, Jann N. Sarkaria, and William F. Elmquist, “Challenges in the Delivery of Therapies to Melanoma Brain Metastases,” Current Pharmacology Reports, 2016. View at Publisher · View at Google Scholar
  • Alessandro Villa, and Stephen Sonis, “Toxicities Associated with Head and Neck Cancer Treatment and Oncology-Related Clinical Trials,” Current Problems in Cancer, 2016. View at Publisher · View at Google Scholar
  • Franky Chandra, Dendi Sandiono, Unwati Sugiri, Oki Suwarsa, and Hendra Gunawan, “Cutaneous Side Effects and Transepidermal Water Loss To Gefitinib: A Study of 11 Patients,” Dermatology and Therapy, 2016. View at Publisher · View at Google Scholar
  • Wenwu Xiao, Tianhong Li, Fernanda C. Bononi, Diana Lac, Ivy A. Kekessie, Yanlei Liu, Eduardo Sanchez, Anisha Mazloom, Ai-hong Ma, Jia Lin, Jimmy Tran, Kevin Yang, Kit S. Lam, and Ruiwu Liu, “Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of alpha 3 integrin-expressing human,” Ejnmmi Research, vol. 6, 2016. View at Publisher · View at Google Scholar
  • S. Xiao, Q. Mu, Y. Wan, and M. Xue, “Spontaneous renal hemorrhage caused by invasive mole: a case report,” European Journal Of Gynaecological Oncology, vol. 37, no. 3, pp. 417–419, 2016. View at Publisher · View at Google Scholar
  • Philip J. O’Halloran, Thomas Viel, David W. Murray, Lydia Wachsmuth, Katrin Schwegmann, Stefan Wagner, Klaus Kopka, Monika A. Jarzabek, Patrick Dicker, Sven Hermann, Cornelius Faber, Tim Klasen, Michael Schäfers, David O’Brien, Jochen H. M. Prehn, Andreas H. Jacobs, and Annette T. Byrne, “Mechanistic interrogation of combination bevacizumab/dual PI3K/mTOR inhibitor response in glioblastoma implementing novel MR and PET imaging biomarkers,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 43, no. 9, pp. 1673–1683, 2016. View at Publisher · View at Google Scholar
  • Caglar Yildiz, Turgut Kacan, Ozlem Bozoklu Akkar, Savas Karakus, Metin Seker, Selen Baloglu Kacan, Hatice Ozer, and Ali Cetin, “Effect of imatinib on growth of experimental endometriosis in rats,” European Journal Of Obstetrics & Gynecology And Reproductive Biology, vol. 197, pp. 159–163, 2016. View at Publisher · View at Google Scholar
  • Ok-Cheol Jeon, Dong-Hyun Seo, Han-Sung Kim, Youngro Byun, and Jin Woo Park, “Oral delivery of zoledronic acid by non-covalent conjugation with lysine-deoxycholic acid: In vitro characterization and in vivo anti-osteoporotic eff,” European Journal Of Pharmaceutical Sciences, vol. 82, pp. 1–10, 2016. View at Publisher · View at Google Scholar
  • Seyedeh Hoda Alavizadeh, Javad Akhtari, Ali Badiee, Shiva Golmohammadzadeh, and Mahmoud Reza Jaafari, “Improved therapeutic activity of HER2 Affibody-targeted cisplatin liposomes in HER2-expressing breast tumor models,” Expert Opinion On Drug Delivery, vol. 13, no. 3, pp. 325–336, 2016. View at Publisher · View at Google Scholar
  • Bianca K. Verlinden, Abraham Louw, and Lyn-Marie Birkholtz, “Resisting resistance: is there a solution for malaria?,” Expert Opinion On Drug Discovery, vol. 11, no. 4, pp. 395–406, 2016. View at Publisher · View at Google Scholar
  • Jody C. Chuang, Ameen A. Salahudeen, and Heather A. Wakelee, “Rociletinib, a third generation EGFR tyrosine kinase inhibitor: current data and future directions,” Expert Opinion On Pharmacotherapy, vol. 17, no. 7, pp. 989–993, 2016. View at Publisher · View at Google Scholar
  • Leonardo Marques da Fonseca, Vanessa Amil da Silva, Leonardo Freire-de-Lima, José Osvaldo Previato, Lucia Mendonça-Previato, and Márcia Alves Marques Capella, “Glycosylation in Cancer: Interplay between Multidrug Resistance and Epithelial-to-Mesenchymal Transition?,” Frontiers in Oncology, vol. 6, 2016. View at Publisher · View at Google Scholar
  • Viktor H. Koelzer, Karl Steuer, Ulrike Camenisch Gross, Dieter Zimmermann, Aino Paasinen-Sohns, Kirsten D. Mertz, and Gieri Cathomas, “Colorectal Choriocarcinoma in a Patient with Probable Lynch Syndrome,” Frontiers in Oncology, vol. 6, 2016. View at Publisher · View at Google Scholar
  • Janella Hudson, Teresita Munoz-Antonia, Eric Haura, Doug Cress, Vani N. Simmons, and Gwendolyn P. Quinn, “Translating Hispanic Genomic Factors in Lung Cancer Into Clinical Practice: EGFR Testing for Improved Outcomes,” Gene, Cell and Tissue, vol. InPress, no. InPress, 2016. View at Publisher · View at Google Scholar